Ivermectin used in a single-drug treatment regime has not shown significant benefits in a number of RCTs. However there is promising evidence of significant benefits when Ivermectin is used as part of a multi-drug treatment regime [1].
Since the beginning of the pandemic many front-line doctors have been combining multi-drug treatment regimes with early (in the symptomatic phase) treatment to successfully reduce hospitalization and death [2][3][4][5][6].
Since the beginning of the pandemic many front-line doctors have been combining multi-drug treatment regimes with early (in the symptomatic phase) treatment to successfully reduce hospitalization and death [2][3][4][5][6].
[1] Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial https://pubmed.ncbi.nlm.nih.gov/33983065/
[2] Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) https://scholarlycommons.henryford.com/cgi/viewcontent.cgi?a...
[3] Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.1...
[4] Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection https://rcm.imrpress.com/EN/article/downloadArticleFile.do?a...
[5] Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents https://www.sciencedirect.com/science/article/abs/pii/S03069...
[6] Multidrug treatment for COVID-19 https://www.jstage.jst.go.jp/article/ddt/advpub/0/advpub_202...